Discontinuation report APO-ATORVASTATIN

Last updated on 2018-09-07 History
Report ID 60276
Drug Identification Number 02295261
Brand name APO-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90 BTL
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-03-17
Actual discontinuation date
Remaining supply date 2019-03-17
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-09-07 French Compare
v1 2018-09-07 English Compare